ArticleCancer biology & therapy2014

The vascular disrupting agent BNC105 potentiates the efficacy of VEGF and mTOR inhibitors in renal and breast cancer.

Daniel J Inglis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.